Sytske Hyke Moolenaar

Title: Sytske Hyke Moolenaar: Innovator in Neurodegenerative Disorder Treatments

Introduction

Sytske Hyke Moolenaar is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of neurodegenerative disorders through his innovative patents. With a total of 3 patents, Moolenaar is dedicated to improving treatment options for patients suffering from these challenging conditions.

Latest Patents

Moolenaar's latest patents include groundbreaking work on the use of edaravone in the oral treatment of oxidative-stress mediated neurodegenerative disorders. This invention involves a liquid aqueous solution of edaravone, which is administered orally to provide a daily dose of 40-120 mg for at least 10 days. The treatment targets various disorders, including amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), cerebral amyloid angiopathy (CAA), Alzheimer's disease, and Parkinson's disease. Another significant patent involves the development of edaravone salts, specifically 3-methyl-1-phenyl-2-pyrazolin-5-one napadisylate and hemi-napadisylate. These salts are easier to manufacture, dissolve more rapidly in water, and are stable and easy to handle.

Career Highlights

Moolenaar is currently associated with Treeway Tw001 B.V., where he continues to advance his research and innovations. His work is pivotal in the pharmaceutical industry, particularly in developing effective treatments for neurodegenerative diseases.

Collaborations

Moolenaar collaborates with talented individuals such as Ronald Van Der Geest and Ana Fernandez Casares, who contribute to his research efforts and innovations.

Conclusion

Sytske Hyke Moolenaar is a prominent inventor whose work in neurodegenerative disorder treatments is making a significant impact. His innovative patents and collaborations are paving the way for improved patient care and treatment options.